Breast Cancer Treatment Relying on Herbal Bioactive Components

Keshamma E.; Anil Kumar; Ritesh Jha; Vandana Sonaji Amle; Gitanjali Sambhajirao Dudhate; Divyakant Patel; Purabi Saha; Roshan Kumar

doi:10.55544/jrasb.1.4.13

Authors

Keshamma E. Associate Professor, Department of Biochemistry, Maharani Cluster University Palace Road, Bangalore – 560001, INDIA.
Dr. Anil Kumar Ex. Research Scholar, Department of Botany, DDU Gorakhpur University Gorakhpur-273009, INDIA.
Ritesh Jha Department of Pharmacy, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun-248007, Uttarakhand, INDIA.
Vandana Sonaji Amle Master of Pharmacy, School of Pharmacy, S.R.T.M.U. Nanded, INDIA.
Gitanjali Sambhajirao Dudhate Department of Pharmaceutics, Indira college of Pharmacy Vishnupuri Nanded-431605, INDIA.
Dr. Divyakant Patel Professor, Sharda School of Pharmacy, Pethapur, Gandhinagar, Gujarat, INDIA.
Purabi Saha Department of Pharmacy, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun-248007, Uttarakhand, INDIA.
Roshan Kumar Assistant Professor, Guru Nanak College of Pharmaceutical Sciences, Dehradun, Uttarakhand, INDIA.

DOI:

https://doi.org/10.55544/jrasb.1.4.13

Keywords:

Breast cancer, Herbs, Bioactive, Medicinal plants

Abstract

Use of herbs and plants in cooking and medicinal dates back thousands of years. In this overview, we look at the many plant species that still have immune-boosting and cancer-fighting properties. Carotenoids, flavonoids, ligands, polyphenolics, terpenoids, sulphides, lignans, and plant sterols are only some of the many active phytochemicals found in different types of herbs. There are a number of mechanisms through which these phytochemicals exert their effects. They either prevent cell division or stimulate the synthesis of a protective enzyme such as glutathione transferase. The cancer-fighting and cholesterol-lowering effects of mevalonate are counteracted by the volatile oils and plant extracts from various herbs and plants.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Kondov B., Milenkovikj Z., Kondov G., Petrushevska G., Basheska N., Bogdanovska-Todorovska M., Tolevska N., Ivkovski L. Presentation of the Molecular Subtypes of Breast Cancer Detected by Immunohistochemistry in Surgically Treated Patients. Open Access Maced. J. Med. Sci. 2018;6:961–967. doi: 10.3889/oamjms.2018.231.

Redig A.J., McAllister S.S. Breast cancer as a systemic disease: A view of metastasis. J. Intern. Med. 2013;274:113–126. doi: 10.1111/joim.12084.

Cordero M.J.A., Villar N.M., Sánchez M.N., Pimentel-Ramírez M.L., García-Rillo A., Valverde E.G. Breast cancer and body image as a prognostic factor of depression: A case study in México City. Nutr Hosp. 2015;31:371–379.

Kumar, R., Saha, P., Lokare, P., Datta, K., Selvakumar, P., & Chourasia, A. (2022). A Systemic Review of Ocimum sanctum (Tulsi): Morphological Characteristics, Phytoconstituents and Therapeutic Applications. International Journal for Research in Applied Sciences and Biotechnology, 9(2), 221-226.

Pan S.Y., Zhou S.F., Gao S.H., Yu Z.L., Zhang S.F., Tang M.K., Sun J.N., Ma D.L., Han Y.F., Fong W.F., et al. New perspectives on how to discover drugs from herbal medicines: CAM’s outstanding contribution to modern therapeutics. Evid. Based Complement. Alternat. Med. 2013;2013:5–12. doi: 10.1155/2013/627375.

Li Y., Li S., Meng X., Gan R.Y., Zhang J.J., Li H.B. Dietary Natural Products for Prevention and Treatment of Breast Cancer. Nutrients. 2017;9:728. doi: 10.3390/nu9070728.

Solowey E., Lichtenstein M., Sallon S., Paavilainen H., Solowey E., Lorberboum-Galski H. Evaluating medicinal plants for anticancer activity. Sci. World J. 2014;2014:1–12. doi: 10.1155/2014/721402.

Moshiri M., Hamid F., Etemad L. Ricin toxicity: Clinical and molecular aspects. Rep. Biochem. Mol. 2016;4:60.

Roshan, K. (2020). Priya damwani, Shivam kumar, Adarsh suman, Suthar Usha. An overview on health benefits and risk factor associated with coffee. International Journal Research and Analytical Review, 7(2), 237-249.

Leitzmann M., Powers H., Anderson A.S., Scoccianti C., Berrino F., Boutron-Ruault M.C., Cecchini M., Espina C., Key J.T., Norat T., et al. European code against cancer 4th Edition: Physical activity and cancer. Cancer. Epidemiol. 2015;39:S46–S55. doi: 10.1016/j.canep.2015.03.009.

Sharma V., Sarkar I.N. Bioinformatics opportunities for identification and study of medicinal plants. Brief. Bioinform. 2013;14:238–250. doi: 10.1093/bib/bbs021.

Cui Z.J., Gao M., Quan Y., Lv B.M., Tong X.Y., Dai T.F., Zhou X.H., Zhang H.Y. Systems Pharmacology-Based Precision Therapy and Drug Combination Discovery for Breast Cancer. Cancers. 2021;13:3586. doi: 10.3390/cancers13143586.

Bind, A., Das, S., Singh, V. D., Kumar, R., Chourasia, A., & Saha, P. Natural Bioactives For The Potential Management Of Gastric Ulceration. Turkish Journal of Physiotherapy and Rehabilitation, 32(3).

Wishart D.S. Current Protoc Bioinformatics. Introduction to Cheminformatics. Volume 14. John Wiley & Sons; Edmonton, AB, Canada: 2007. pp. 1–9.

Carey L.A. Through a glass darkly: Advances in understanding breast cancer biology, 2000–2010. Clin. Breast Cancer. 2010;10:188–195. doi: 10.3816/CBC.2010.n.026.

Sahana, S. (2020). Purabi saha, Roshan kumar, Pradipta das, Indranil Chatterjee, Prasit Roy, Sk Abdur Rahamat. A Review of the 2019 Corona virus (COVID-19) World Journal of Pharmacy and Pharmaceutical science, 9(9), 2367-2381.

Shao M.M., Chan S.K., Yu A.M., Lam C.C., Tsang J.Y., Lui P.C., Law B.K., Tan P.H., Tse G.M. Keratin expression in breast cancers. Virchows Arch. 2012;461:313–322. doi: 10.1007/s00428-012-1289-9.

Yersal O., Barutca S. Biological subtypes of breast cancer: Prognostic and therapeutic implications. World. J. Clin. Oncol. 2014;5:412–424. doi: 10.5306/wjco.v5.i3.412.

Jia R., Li Z., Liang W. Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis. World. J. Surg. Oncol. 2020;18:268. doi: 10.1186/s12957-020-02042-z.

Nyarko, R. O., Prakash, A., Kumar, N., Saha, P., & Kumar, R. (2021). Tuberculosis a globalized disease. Asian Journal of Pharmaceutical Research and Development, 9(1), 198-201.

Rakha E.A., Elsheiskh S.E., Aleskandarany M.A., Habashi H.O., Green A.R., Powe D.G., El-Sayed M.E., Benhasouna A., Brunet J.S., Akslen L.A., et al. Triple-negative breast cancer: Distinguish between basal and non-basal subtypes. Clin. Cancer Res. 2009;15:2302–2310. doi: 10.1158/1078-0432.CCR-08-2132.

Samavat H., Ursin G., Emory T.H., Lee E., Wang R., Torkelson C.J., Dostal A.M., Swenson K., Le C.T., Yang C.S., et al. A randomized controlled trial of green tea extract supplementation and mammographic density in postmenopausal women at increased risk of breast cancer. Cancer Prev. Res. 2017;12:710–718. doi: 10.1158/1940-6207.CAPR-17-0187.

Tyagi T., Treas J.N., Mahalingaiah P.K., Singh K.P. Potentiation of growth inhibition and epigenetic modulation by combination of green tea polyphenol and 5-aza-2′-deoxycytidine in human breast cancer cells. Breast Cancer Res. Treat. 2015;149:655–668. doi: 10.1007/s10549-015-3295-5.

Saha, P., Kumar, R., Nyarko, R. O., Kahwa, I., & Owusu, P. (2021). HERBAL SECONDARY METABOLITE FOR GASTRO-PROTECTIVE ULCER ACTIVITY WITH API STRUCTURES.

Bright-Gbebry M., Makambi K.H., Rohan J.P., Llanos A.A., Rosenberg L., Palmer J.R., Adams-Campbell L.L. Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: The black women’s health study. BMC Complement. Altern. Med. 2011;11:30. doi: 10.1186/1472-6882-11-30.

Huntimer E.D., Halaweish F.T., Chase C.C.L. Proliferative activity of Echinacea angustifolia root extracts on cancer cells: Interference with doxorubicin cytotoxicity. Chem. Biodivers. 2006;3:695–703. doi: 10.1002/cbdv.200690071.

Su S., Cheng X., Wink M. Natural lignans from Arctium lappa modulate P-glycoprotein efflux function in multidrug resistant cancer cells. Phytomedicine. 2015;22:301–307. doi: 10.1016/j.phymed.2014.12.009.

Sahana, S. (2020). Roshan kumar, Sourav nag, Reshmi paul, Nilayan guha, Indranil Chatterjee. A Review on Alzheimer disease and future prospects. World Journal of Pharmacy and Pharmaceutical science, 9(9), 1276-1285.

Feng T., Cao W., Shen W., Zhang L., Gu X., Guo Y., Tsai H.I., Liu X., Li J., Zhang J., et al. Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy. Oncotarget. 2017;8:329–344. doi: 10.18632/oncotarget.13393.

Tourre A., Xueming X. Flaxseed lignans: Source, biosynthesis, metabolism, antioxidant activity, bio-active components, and health benefits. Comp. Rev. Food Sci. Food Saf. 2010;9:261–269. doi: 10.1111/j.1541-4337.2009.00105.x.

Chen J., Stavro P.M., Thompson L.U. Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr. Cancer. 2002;43:187–192. doi: 10.1207/S15327914NC432_9.

Nyarko, R. O., Saha, P., Kumar, R., Kahwa, I., Boateng, E. A., Boateng, P. O., ... & Bertram, A. (2021). Role of Cytokines and Vaccines in Break through COVID 19 Infections. Journal of Pharmaceutical Research International, 33, 2544-2549.

Cotterchio M., Boucher B.A., Kreiger N., Mills C.A., Thompson L.U. Dietary phytoestrogen intake—Lignans and isoflavones—And breast cancer risk (Canada) Cancer Causes Control. 2008;19:259–272. doi: 10.1007/s10552-007-9089-2.

Khankari N.K., Bradshaw P.T., Steck S.E., He K., Olshan A.F., Shen J. Polyunsaturated fatty acid interactions and breast cancer incidence: A population-based case-control study on Long Island, New York. Ann. Epidemiol. 2015;25:929–935. doi: 10.1016/j.annepidem.2015.09.003.

Thanos J., Cotterchio M., Boucher B.A., Kreiger N., Thompson L.U. Adolescent dietary phytoestrogen intake and breast cancer risk (Canada) Cancer Causes Control. 2006;17:1253–1261. doi: 10.1007/s10552-006-0062-2.

Nyarko, R. O., Kumar, R., Sharma, S., Chourasia, A., Roy, A., & Saha, P. (2022). ANTIBACTERIAL ACTIVITY OF HERBAL PLANT-TINOSPORA CORDIFOLIA AND CATHARNTHUS ROSEUS.

Buck K., Vrieling A., Zaineddin A.K., Becker S., Hüsing A., Kaaks R., Linseisen J., Flesch-Janys D., Chang-Claude J. Serum enterolactone and prognosis of postmenopausal breast cancer. J. Clin. Oncol. 2011;29:3730–3738. doi: 10.1200/JCO.2011.34.6478.

Sundaravadivelu S., Raj S.K., Kumar B.S., Arumugamand P., Ragunathan P.P. Reverse screening bioinformatics approach to identify potential anti breast cancer targets using thymoquinone from neutraceuticals black Cumin il. Anticancer Agents Med. Chem. 2019;19:599–609. doi: 10.2174/1871520619666190124155359.

Dilshad A., Abulkhair O., Nemenqani D., Tamimi W. Antiproliferative properties of methanolic extract of Nigella sativa against the MDA-MB-231 cancer cell line. Asian Pac. J. Cancer Prev. 2012;13:5839–5842. doi: 10.7314/APJCP.2012.13.11.5839.

PURABISAHA, R. K., RAWAT, S. S. N., & PRAKASH, A. (2021). A REVIEW ON NOVEL DRUG DELIVERY SYSTEM.

Imran M., Rauf A., Khan I.A., Khan I.A., Shahbaz M., Qaisrani T.B., Fatmawati S., Abu-Izneid T., Imran A., Rahman K.U., et al. Thymoquinone: A novel strategy to combat cancer: A review. Biomed. Pharmacother. 2018;106:390–402. doi: 10.1016/j.biopha.2018.06.159.

Lee S.R., Mun J.Y., Jeong M.S., Lee H.H., Roh Y.G., Kim W.T., Kim M.H., Heo J., Choi Y.H., Kim S.J., et al. Thymoquinone-induced tristetraprolin inhibits tumor growth and metastasis through destabilization of MUC4 mRNA. Int. J. Mol. Sci. 2019;20:2614. doi: 10.3390/ijms20112614.

Kumar, R., Saha, P., Kumar, Y., Sahana, S., Dubey, A., & Prakash, O. (2020). A Review on Diabetes Mellitus: Type1 & Type2. World Journal of Pharmacy and Pharmaceutical Sciences, 9(10), 838-850.

Linjawi S.A., Khalil W.K., Hassanane M.M., Ahmed E.S. Evaluation of the protective effect of Nigella sativa extract and its primary active component thymoquinone against DMBA-induced breast cancer in female rats. Arch. Med. Sci. 2015;11:220–229. doi: 10.5114/aoms.2013.33329.

Periasamy V.S., Athinarayanan J., Alshatwi A.A. Anticancer activity of an ultrasonic nanoemulsion formulation of Nigella sativa L. essential oil on human breast cancer cells. Ultrason. Sonochem. 2016;31:449–455. doi: 10.1016/j.ultsonch.2016.01.035.

Harper N.W., Hodges K.B., Stewart R.L., Wu J., Huang B., O’Connor K.L., Romond E.H. Adjuvant treatment of triple-negative metaplastic breast cancer with weekly paclitaxel and platinum chemotherapy: Retrospective case review from a single institution. Clin. Breast Cancer. 2019;19:e495–e500. doi: 10.1016/j.clbc.2019.05.009.

Nyarko, R. O., Boateng, E., Kahwa, I., Boateng, P. O., & Asare, B. (2020). The impact on public health and economy using lockdown as a tool against COVID-19 pandemic in Africa: a perspective. J Epidemiol Public Health Rev, 5(3).

Perroud H.A., Alasino C.M., Rico M.J., Mainetti L.E., Queralt F., Pezzotto S.M., Rozados V.R., Scharovsky O.G. Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: Clinical outcomes and biomarkers of response. Cancer Chemother. Pharmacol. 2016;77:365–374. doi: 10.1007/s00280-015-2947-9.

Odeh F., Ismail S.I., Abu-Dahab R., Mahmoud I.S., Al Bawab A. Thymoquinone in liposomes: A study of loading efficiency and biological activity towards breast cancer. Drug Deliv. 2012;19:371–377. doi: 10.3109/10717544.2012.727500.

Kumar, R., Saha, P., Pathak, P., Mukherjee, R., Kumar, A., & Arya, R. K. EVOLUTION OF TOLBUTAMIDE IN THE TREATMENT OF DIABETES MELLITUS. Jour. of Med. P’ceutical & Alli. Sci, 9.

Ahmed S., Othman N.H. Honey as a potential natural anticancer agent: A review of its mechanisms. Evid. Based Complement Altern. Med. 2013;2013:829070. doi: 10.1155/2013/829070.

Teiten M.H., Eifes S., Dicato M., Diederich M. Curcumin—The paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins. 2010;2:128–162. doi: 10.3390/toxins2010128.

Wang N., Wang Z.Y., Mo S.L., Loo T.Y., Wang D.M., Luo H.B. Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer. Breast Cancer Res. Treat. 2012;134:943–955. doi: 10.1007/s10549-012-1977-9.

Rwigemera A., Mamelona J., Martin L.J. Comparative effects between fucoxanthinol and its precursor fucoxanthin on viability and apoptosis of breast cancer cell lines MCF-7 and MDA-MB-231. Anticancer Res. 2015;35:207–219.

Daharia, A., Jaiswal, V. K., Royal, K. P., Sharma, H., Joginath, A. K., Kumar, R., & Saha, P. (2022). A Comparative review on ginger and garlic with their pharmacological Action. Asian Journal of Pharmaceutical Research and Development, 10(3), 65-69.

Li T., Pan H., Feng Y., Li H., Zhao Y. Bioactivity-guided isolation of anticancer constituents from Hedera nepalensis K. Koch. South Afr. J. Bot. 2015;100:87–93. doi: 10.1016/j.sajb.2015.05.011.

Xia J., Cheng L., Mei C., Ma J., Shi Y., Zeng F., Wang Z., Wang Z. Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells. Curr. Pharm. Des. 2014;20:5348–5353. doi: 10.2174/1381612820666140128215756.

Bakshi H., Sam S., Rozati R., Sultan P., Islam T., Rathore B., Lone Z., Sharma M., Triphati J., Saxena R.C. DNA fragmentation and cell cycle arrest: A hallmark of apoptosis induced by crocin from kashmiri saffron in a human pancreatic cancer cell line. Asian Pac. J. Cancer Prev. 2010;11:675–679.

Saha, P., Nyarko, R. O., Lokare, P., Kahwa, I., Boateng, P. O., & Asum, C. (2022). Effect of Covid-19 in Management of Lung Cancer Disease: A Review. Asian Journal of Pharmaceutical Research and Development, 10(3), 58-64.

Ming D.S., Hillhouse B.J., Guns E.S., Eberding A., Xie S., Vimalanathan S., Towers G.N. Bioactive compounds from Rhodiola rosea (Crassulaceae) Phyther. Res. An. Int. J. Devoted to Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 2005;19:740–743. doi: 10.1002/ptr.1597.

Lee Y.K., Bone N.D., Strege A.K., Shanafelt T.D., Jelinek D.F., Kay N.E. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood. 2004;104:788–794. doi: 10.1182/blood-2003-08-2763.

Kumar, R., Jain, A., Tripathi, A. K., & Tyagi, S. (2021, January). Covid-19 outbreak: An epidemic analysis using time series prediction model. In 2021 11th international conference on cloud computing, data science & engineering (Confluence) (pp. 1090-1094). IEEE.

Zhao G., Han X., Zheng S., Li Z., Sha Y., Ni J. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells. Oncol. Rep. 2016;35:1065–1074. doi: 10.3892/or.2015.4413.

Ahmadiankia N, Moghaddam HK, Mishan MA, Bahrami AR, Naderi-Meshkin H, Bidkhori HR, et al. Berberine suppresses migration of MCF-7 breast cancer cells through down-regulation of chemokine receptors. Iran J Basic Med Sci. 2016;19:125–131.

Zhao Y, Jing Z, Li Y, Mao W. Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis. Oncol Rep. 2016;36:567–572.

KUMAR, A. (2019). The Scenario of Pharmaceuticals and Development of Microwave Assisted Extraction Techniques.

Li X, Wang X, Xie C, Zhu J, Meng Y, Chen Y, et al. Sonic hedgehog and Wnt/beta-catenin pathways mediate curcumin inhibition of breast cancer stem cells. Anti-cancer drugs. 2018;29:208–215.

Kakarala M, Brenner DE, Korkaya H, Cheng C, Tazi K, Ginestier C, et al. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat. 2010;122:777–785.

Zhou Q, Ye M, Lu Y, Zhang H, Chen Q, Huang S, et al. Curcumin improves the tumoricidal effect of mitomycin C by suppressing ABCG2 expression in stem cell-like breast cancer cells. PloS one. 2015;10:1–12.

Kumar, R., & Saha, P. (2022). A review on artificial intelligence and machine learning to improve cancer management and drug discovery. International Journal for Research in Applied Sciences and Biotechnology, 9(3), 149-156.

Yuan JD, ZhuGe DL, Tong MQ, Lin MT, Xu XF, Tang X, et al. pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer. Artif Cells Nanomed Biotechnol. 2018;46:302–313.

Cook MT, Liang Y, Besch-Williford C, Goyette S, Mafuvadze B, Hyder SM. Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts. Springerplus. 2015;4:1–16.

SHAFQAT ZAIDI, R. K., MEHRA, D., & ROSHAN, K. A. D. (2021). Effect of Kalahari Cactus Extract on Appetitte, Body Weight And Lipid Profile In Cafeteria Diet Induced Obesity In Experimental Animal. Annals of the Romanian Society for Cell Biology, 25(6), 13976-13987.

Pan X, Zhao B, Song Z, Han S, Wang M. Estrogen receptor-alpha36 is involved in epigallocatechin-3-gallate induced growth inhibition of ER-negative breast cancer stem/progenitor cells. J Pharmacol Sci. 2016;130:85–93.

Saha, P., Kumar, A., Bhanja, J., Shaik, R., Kawale, A. L., & Kumar, R. (2022). A Review of Immune Blockade Safety and Antitumor Activity of Dostarlimab Therapy in Endometrial Cancer. International Journal for Research in Applied Sciences and Biotechnology, 9(3), 201-209.

Montales MTE, Rahal OM, Kang J, Rogers T, Prior RL, Wu X, et al. Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells. Carcinogenesis. 2012;33:652–660.

Montales MTE, Rahal OM, Nakatani H, Matsuda T, Simmen RC. Repression of mammary adipogenesis by genistein limits mammosphere formation of human MCF-7 cells. J Endocrinol. 2013;218:135–149.

Singh, Y., Paswan, S. K., Kumar, R., Otia, M. K., Acharya, S., Kumar, D., & Keshamma, E. (2022). Plant & Its Derivative Shows Therapeutic Activity on Neuroprotective Effect. Journal for Research in Applied Sciences and Biotechnology, 1(2), 10-24.

Rigalli J, Tocchetti G, Arana M, Villanueva S, Catania V, Theile D, et al. The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters. Cancer lett. 2016;376:165–172.

Wang Z, Zhang X, Wang H, Qi L, Lou Y. Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway. Neuroscience. 2007;145:911–922.

Kumar, R., Keshamma, E., Paswan, S. K., Saha, P., Trivedi, U., Chourasia, A., & Otia, M. (2022). Alkaloid Based Chemical Constituents of Ocimum santum & Cinchona Bark: A Meta Analysis. Journal for Research in Applied Sciences and Biotechnology, 1(2), 35-42.

Wang X, Zheng N, Dong J, Wang X, Liu L, Huang J. Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells. J Steroid Biochem Mol Biol. 2017;171:318–327.

Kwon SJ, Park SY, Kwon GT, Lee KW, Kang Y-H, Choi M-S, et al. Licochalcone E present in licorice suppresses lung metastasis in the 4T1 mammary orthotopic cancer model. Cancer Prev Res. 2013;6:603–613.

Nyarko, R. O., Roopini, R., Raviteja, V., Awuchi, C. G., Kumar, R., Faller, E. M., ... & Saha, P. (2022). Novel Sars-CoV-2 Variants & Therapeutic Effects. Journal for Research in Applied Sciences and Biotechnology, 1(2), 25-34.

Sajadian S, Vatankhah M, Majdzadeh M, Kouhsari SM, Ghahremani MH, Ostad SN. Cell cycle arrest and apoptogenic properties of opium alkaloids noscapine and papaverine on breast cancer stem cells. Toxicol Mech Methods. 2015;25:388–395.

Amle, V. S., Rathod, D. A., Keshamma, E., Kumar, V., Kumar, R., & Saha, P. (2022). Bioactive Herbal Medicine Use for Eye Sight: A Meta Analysis. Journal for Research in Applied Sciences and Biotechnology, 1(3), 42-50.

Zhang Y, Piao B, Zhang Y, Hua B, Hou W, Xu W, et al. Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells. Med Oncol. 2011;28:99–107.

Chen Y, Chen L, Zhang JY, Chen ZY, Liu TT, Zhang YY, et al. Oxymatrine reverses epithelial-mesenchymal transition in breast cancer cells by depressing alphabeta3 integrin/FAK/PI3K/Akt signaling activation. Onco Targets Ther. 2019;12:6253–6265.

Pandey, M., Singh, A., Agnihotri, N., Kumar, R., Saha, P., Pandey, R. P., & Kumar, A. (2022). Clinical Pharmacology & Therapeutic uses of Diuretic Agents: A Review. Journal for Research in Applied Sciences and Biotechnology, 1(3), 11-20.

Lai LH, Fu QH, Liu Y, Jiang K, Guo QM, Chen QY, et al. Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model. Acta Pharmacol Sin. 2012;33:523–530.